ANZGOG 0902/GOG-0274: A phase III trial of adjuvant chemotherapy as primary treatment for locally advanced cervical cancer compared to chemoradiation alone: The Outback Trial.
?
CTSU C90601: A randomized double-blinded phase III study comparing gemcitabine, cisplatin, and bevacizumab (IND #7921, NSC #704865) to gemcitabine, cisplatin, and placebo in patients with advanced transitional cell carcinoma.
?
ECOG E2607: A phase II trial of dasatanib in KIT-positive patients with unresectable locally advanced or stage IV mucosal, acral and vulvovaginal melanomas.
?
GOG 0127W: A phase II evaluation of ABT-888 (IND #77840, NSC #737664), topotecan (NSC #609699) and filgrastim or pegfilgrastim in the treatment of persistent or recurrect squamous or non-squamous cell carcinoma of the cervix.
?
GOG 0131H: Phase II evaluation of ixabepilone (IND #59699, NSC #710428) in the treatment of recurrent or persistent leiomyosarcoma of the uterus.
?
GOG 0186I: A randomized phase II evaluation of singe-agent bevacizumab (IND #7921) (NSC #704865) and combination bevacizumab with fosbretabulin tromethamine (CA4P) (NSC #752293) in the treatment of recurrent or persistent epithelial ovarian, fallopian tube or primary peritoneal carcinoma.
?
GOG 0187: Phase II study of paclitaxel for ovarian stromal tumors as second-line therapy.
?
GOG 0212: A randomized phase III trial of maintenance chemotherapy comparing 12 monthly cycles of single agent paclitaxel or CT-2103 (IND #70177) vs. no treatment until documented relapse in women with advanced ovarian, primary peritoneal or fallopian tube cancer who achieve a complete clinical response to primary platinum/taxane chemotherapy.
?
GOG 0213: A phase III randomized controlled clinical trial of carboplatin and paclitaxel alone or in combination with bevacizumab (NSC #704865, IND #113912) followed by bevacizumab and secondary cytoreductive surgery in platinum-sensitive, recurrent ovarian, fallopian tube and peritoneal primary cancer.
?
GOG 0221: Glycoprotein and glycan profiling in patients with locally advanced cervical cancer (stage IB2, IIA > 4cm, IIB to IVA) undergoing pelvic and para-aortic (abdominal) lymphadenectomy.
?
GOG 0229K: A phase II evaluation of BIBF1120 (IND #113086) in the treatment of recurrent or persistent endometrial carcinoma.
?
GOG 0235: A prospective, longitudinal study of YKL-40 in patients with FIGO stage III or IV invasive epithelial ovarian, primary peritoneal, or fallopian tube cancer undergoing primary chemotherapy.
?
GOG 0238: A randomized trial of pelvic irradiation with or without concurrent weekly cisplatin in patients with pelvic-only recurrence of carcinoma of the uterine corpus.
?
GOG 0241: A GCIG intergroup multicenter phase III trial of open label carboplatin and paclitaxel +/- NCI supplied agent: bevacizumab (NSC #704865, IND #113912) compared with oxaliplatin and capecitabine +/- bevacizumab as first line chemotherapy in patients with mucinous epithelial ovarian or fallopian tube cancer (MEOC).
?
GOG 0249: A phase III trial of pelvic radiation therapy vs. vaginal cuff brachytherapy followed by paclitaxel/carboplatin in chemotherapy in patients with high-risk, early stage endometrial carcinoma.
?
GOG 0250: A randomized phase III evaluation of docetaxel (NSC #628503) and gemcitabine (NSC #613327) plus G-CSF with bevacizumab (NSC #704865, IND #113912) vs. docetaxel (NSC #628503) and gemcitabine (NSC #613327) plus G-CSF with placebo in the treatment of recurrent or advanced leiomyosarcoma of the uterus.
?
GOG 0254: A phase II evaluation of SU11248 (sunitinib malate) (IND #74019, NSC #736511) in the treatment of persistent or recurrent clear cell ovarian carcinoma.
?
GOG 0258: A randomized phase III trial of cisplatin and tumor volume directed irradiation followed by carboplatin and paclitaxel vs. carboplatin and paclitaxel for optimally debulked, advanced endometrial carcinoma.
?
GOG 0261: A randomized phase III trial of paclitaxel plus carboplatin vs. ifosfamide plus paclitaxel in chemotherapy-na?ve patients with newly diagnosed stage I-IV persistent or recurrent carcinosarcoma (mixed mesodermal tumors) of the uterus or ovary.
?
GOG 0263: Randomized phase III clinical trial of adjuvant radiation vs. chemoradiation in intermediate risk, stage I/IIA cervical cancer treated with initial radical hysterectomy and pelvic lymphadenectomy.
?
GOG 0264: A randomized phase II trial of paclitaxel and carboplatin vs. bleomycin, etoposide and cisplatin for newly diagnosed advanced stage and recurrent chemonaive stage sex cord-stromal tumors of the ovary.
?
GOG 0273: Chemotherapy toxicity in elderly women with ovarian, primary peritoneal or fallopian tube cancer.
?
RTOG 0724: Phase III randomized study of concurrent chemotherapy and pelvic radiation therapy with or without adjuvant chemotherapy in high-risk patients with early-stage cervical carcinoma following radical hysterectomy.
Tags: Gynecologic, WMCC Clinical Trial
Source: http://www.wmcc.org/2012/07/gynecologic/
shooting at chardon high school sasha baron cohen stacy keibler stacy keibler all star game oscar red carpet daytona 500 start time
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.